This site is intended for healthcare professionals
Scalp and hair follicles, cellular image, blue overlay

Alopecia areata

Last updated: 2nd Jan 2026

Alopecia areata (AA) is caused by the immune system erroneously attacking hair follicles, leading to inflammation. While researchers are not entirely sure why this immune attack occurs, they suspect that both genetic and environmental factors contribute. AA mainly causes hair loss, though it can sometimes cause changes in the nails, such as pits. People with this condition are generally healthy and exhibit no other symptoms.


How common is AA?

Approximately 2% of the global population will experience AA at some point during their lifetime, meaning approximately 160 million people have had or will have AA.


Who is most at risk?

While AA can affect anyone, regardless of gender, race, or age, it is most common in teens, twenties, and thirties. It tends to be more severe in children under 10. Autoimmune diseases and allergic conditions increase the risk of developing AA. Emotional stress or illness might trigger it, but often there's no clear cause.


How does AA impact quality of life?

AA has a negative impact on mental health, which can lead to anxiety, depression, suicidal thoughts, and increased psychiatric hospitalizations. People with AA may also have poorer attendance and productivity at work/school, likely due to new-onset anxiety/depression or visible hair loss. Overall, AA’s impact goes far beyond aesthetic considerations, negatively impacting numerous aspects of an individual’s life.


What treatments are available for AA?

Treatments for AA include Janus kinase (JAK) inhibitors, corticosteroids (oral and injectable methods available), immunosuppressants, and other medications that inhibit the disease process. The main aim of therapy is to prevent the immune system from attacking hair follicles and promote the regrowth of hair.


Developed by EPG Health for Medthority, independently of any sponsor.

Latest resources

Alopecia areata webinar

Watch a webinar addressing alopecia areata in skin of color populations, chaired by Antonella Tosti.

WATCH NOW

Addressing inclusivity in AA assessment

View “Inclusive Care in Alopecia” for an in-depth look at how to better support skin of color populations with alopecia areata.

View

Welcome:

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.